Rapid progression of marginal zone b-cell lymphoma after covid-19 vaccination (bnt162b2): a case report

HIGHLIGHTS

  • who: Kenichi Hashimoto from the Sultan Qaboos University, Oman Pescara, Italy have published the paper: Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report, in the Journal: (JOURNAL)

SUMMARY

    Her second vaccination) because the right temporal mass had not disappeared. Although a few cases of recurrence, progression, or regression of T-cell lymphoma after mRNA COVID-19 vaccinations were reported, an influence of these vaccines on B-cell lymphomas has not been reported to date. Recommendations by the Canadian Society of Breast Imaging, Society of Breast . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?